Bringing BsAbs Home: Building Outpatient Care as Volume Grows
Availability
On-Demand
Cost
$0.00

The final Bispecific Antibodies (BsAbs) Office Hour brought multidisciplinary providers together to explore how programs are scaling outpatient BsAb delivery, adapting to a changing treatment landscape, and building a sustainable business case.

Objectives:

  • Compare outpatient care delivery models
  • Discuss changes in BsAb delivery and their impact
  • Understand the business case for BsAb delivery

 

Cara Harshberger, PharmD, BCOP
Clinical Pharmacist, Pharmacy
Ivinson Memorial Hospital
Laramie, WY

Kirollos S. Hanna, PharmD, BCPS, BCOP, FACCC, FAPO, FHOPA
Director of Pharmacy
Minnesota Oncology
Assistant Professor of Pharmacy
Mayo Clinic School of Medicine
St. Paul, MN

Donald Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP, FAPO
Clinical Oncology Pharmacy Manager
Levine Cancer Institute, Atrium Cancer Center
Charlotte, NC

 

 




Powered By